Clinical impact of hepatitis B and C virus envelope glycoproteins

doi:10.3748/wjg.v19.i5.654

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8602)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

655

HTML

6070

Figures (1-3)

271

Tables (1-1)

111

Sum=7107

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

846

Download

649

Sum=1495

Feb 7, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Feb 7, 2013; 19(5): 654-664
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.654

Full Size Figure Download Figure

Figure 1 Schematic representation of hepatitis B virus envelope proteins and genome. Hepatitis B virus (HBV) surface envelope antigen includes three viral surface glycoproteins, named large, medium, and small proteins (LHBs, MHBs and SHBs). Their expression is directed by the S gene including three start codons and one stop codon in a single open reading frame.

Citation: Jeulin H, Velay A, Murray J, Schvoerer E. Clinical impact of hepatitis B and C virus envelope glycoproteins. World J Gastroenterol 2013; 19(5): 654-664
URL: https://www.wjgnet.com/1007-9327/full/v19/i5/654.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i5.654